Evoke plc (LON:EVOK – Get Free Report)’s stock price dropped 10% on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares changed hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Ratings Changes
Several equities research analysts have recently issued reports on the stock. Jefferies Financial Group reissued a “buy” rating and set a GBX 140 ($1.81) target price on shares of Evoke in a research note on Monday, December 16th. Berenberg Bank dropped their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research report on Wednesday, December 4th.
Get Our Latest Stock Report on Evoke
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last released its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Equities research analysts expect that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Activity at Evoke
In other news, insider Andrea Gisle Joosen purchased 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were bought at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). 27.00% of the stock is owned by insiders.
About Evoke
Read More
- Five stocks we like better than Evoke
- The Most Important Warren Buffett Stock for Investors: His Own
- MarketBeat Week in Review – 03/24 – 03/28
- 3 REITs to Buy and Hold for the Long Term
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Using the MarketBeat Dividend Yield Calculator
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.